Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents
Article in Expert Review of Neurotherapeutics (March 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
X-linked Malformation Deafness: Neurodevelopmental Symptoms Are Common in Children With IP3 Malformation and Mutation in POU3F4
Article in Ear & Hearing (June 2021)
Association of Serotonin Receptors with Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis
Article in Current Medical Science (June 2018)